Loading clinical trials...

Cardiac Function Non-Invasive Monitoring System Evaluation Trial | Clinical Trials | Clareo Health

COMPLETED

Cardiac Function Non-Invasive Monitoring System Evaluation Trial

Cardiac Function Monitoring System Evaluation

NCT04131725•Sensydia Corporation

Summary

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Detailed Description

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Adults of age 18 or older

Exclusion Criteria

•Subjects with wounds or surgical incisions at the site of sensor placement

Locations (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Key Dates

Start Date

November 9, 2020

Primary Completion Date

February 1, 2023

Completion Date

April 30, 2023

Last Updated

November 22, 2023

Enrollment

275

ACTUAL participants

Conditions

Cardiac Disease

Interventions

Cardiac Performance System (NSR)

DEVICE

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

NCT07032792

Cardiac DiseaseSurgery+1 more

View study

RECRUITING

The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning

NCT07274436

Cardiac Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 22, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Cardiac Function Non-Invasive Monitoring System Evaluation Trial

Inclusion Criteria

Exclusion Criteria

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning

A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging

Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART

Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease